Hospital mark-ups of drug costs—which can be as high as 1,000 percent—is the subject of a new analysis sponsored by the Pharmaceutical Research and Manufacturers of America (PhRMA).
The report, conducted by The Moran Company but commissioned by PhRMA, finds that nearly one in five hospitals in the U.S. mark up medicine prices 700 percent or more. The analysis found that eight percent of hospitals marked up some medicine prices more than 1,000 percent.
“Hospitals receive billions of dollars every year in negotiated and mandatory discounts from biopharmaceutical companies while simultaneously increasing the price of these medicines to insurers and patients,” said Stephen J. Ubl, president and chief executive officer of PhRMA. “In order to make medicines more affordable for patients, we must address the role hospital markups play in driving up medicine costs.”
Continue Reading for Free
Register and gain access to:
- Breaking benefits news and analysis, on-site and via our newsletters and custom alerts
- Educational webcasts, white papers, and ebooks from industry thought leaders
- Critical converage of the property casualty insurance and financial advisory markets on our other ALM sites, PropertyCasualty360 and ThinkAdvisor
Already have an account? Sign In Now
© 2024 ALM Global, LLC, All Rights Reserved. Request academic re-use from www.copyright.com. All other uses, submit a request to [email protected]. For more information visit Asset & Logo Licensing.